356 related articles for article (PubMed ID: 21748193)
21. Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy.
Zou Q; Fang Y; Zhao Y; Zhao H; Wang Y; Gu Y; Wu F
J Med Chem; 2013 Jul; 56(13):5288-94. PubMed ID: 23763331
[TBL] [Abstract][Full Text] [Related]
22. Photocytotoxic activity of a nitrosyl phthalocyanine ruthenium complex--a system capable of producing nitric oxide and singlet oxygen.
Carneiro ZA; de Moraes JC; Rodrigues FP; de Lima RG; Curti C; da Rocha ZN; Paulo M; Bendhack LM; Tedesco AC; Formiga AL; da Silva RS
J Inorg Biochem; 2011 Aug; 105(8):1035-43. PubMed ID: 21726765
[TBL] [Abstract][Full Text] [Related]
23. [Development of a new photosensitizer on the basis of ytterbium porphyrazine complex].
Shirmanova MV; Balalaeva IV; Lekanova NIu; Mysiagin SA; Brilkina AA; Klapshina LG; Zagaĭnova EV
Biofizika; 2011; 56(6):1117-24. PubMed ID: 22279757
[TBL] [Abstract][Full Text] [Related]
24. A new heteroleptic ruthenium(II) polypyridyl complex with long-wavelength absorption and high singlet-oxygen quantum yield.
Zhou QX; Lei WH; Chen JR; Li C; Hou YJ; Wang XS; Zhang BW
Chemistry; 2010 Mar; 16(10):3157-65. PubMed ID: 20108277
[TBL] [Abstract][Full Text] [Related]
25. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
26. One- and two-photon singlet oxygen generation with new fluorene-based photosensitizers.
Andrasik SJ; Belfield KD; Bondar MV; Hernandez FE; Morales AR; Przhonska OV; Yao S
Chemphyschem; 2007 Feb; 8(3):399-404. PubMed ID: 17226876
[TBL] [Abstract][Full Text] [Related]
27. Ru(II) complexes of new tridentate ligands: unexpected high yield of sensitized 1O2.
Liu Y; Hammitt R; Lutterman DA; Joyce LE; Thummel RP; Turro C
Inorg Chem; 2009 Jan; 48(1):375-85. PubMed ID: 19035764
[TBL] [Abstract][Full Text] [Related]
28. Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy.
Zhao T; Shen X; Li L; Guan Z; Gao N; Yuan P; Yao SQ; Xu QH; Xu GQ
Nanoscale; 2012 Dec; 4(24):7712-9. PubMed ID: 23132010
[TBL] [Abstract][Full Text] [Related]
29. Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins.
McCarthy JR; Weissleder R
ChemMedChem; 2007 Mar; 2(3):360-5. PubMed ID: 17245681
[TBL] [Abstract][Full Text] [Related]
30. Metallation of pentaphyrin with Lu(III) dramatically increases reactive-oxygen species production and cell phototoxicity.
Ballico M; Rapozzi V; Xodo LE; Comuzzi C
Eur J Med Chem; 2011 Feb; 46(2):712-20. PubMed ID: 21216052
[TBL] [Abstract][Full Text] [Related]
31. Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitizers for photodynamic therapy.
Milanesio ME; Alvarez MG; Rivarola V; Silber JJ; Durantini EN
Photochem Photobiol; 2005; 81(4):891-7. PubMed ID: 15757366
[TBL] [Abstract][Full Text] [Related]
32. Studies on the Synthesis, Photophysical and Biological Evaluation of Some Unsymmetrical Meso-Tetrasubstituted Phenyl Porphyrins.
Boscencu R; Manda G; Radulea N; Socoteanu RP; Ceafalan LC; Neagoe IV; Ferreira Machado I; Basaga SH; Vieira Ferreira LF
Molecules; 2017 Oct; 22(11):. PubMed ID: 29068406
[No Abstract] [Full Text] [Related]
33. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
34. Highly selective mitochondria-targeting amphiphilic silicon(IV) phthalocyanines with axially ligated rhodamine B for photodynamic therapy.
Zhao Z; Chan PS; Li H; Wong KL; Wong RN; Mak NK; Zhang J; Tam HL; Wong WY; Kwong DW; Wong WK
Inorg Chem; 2012 Jan; 51(2):812-21. PubMed ID: 22191427
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
[TBL] [Abstract][Full Text] [Related]
36. Heterometallic Ru-Pt metallacycle for two-photon photodynamic therapy.
Zhou Z; Liu J; Rees TW; Wang H; Li X; Chao H; Stang PJ
Proc Natl Acad Sci U S A; 2018 May; 115(22):5664-5669. PubMed ID: 29760069
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic agents with anti-metastatic activities.
Vummidi BR; Noreen F; Alzeer J; Moelling K; Luedtke NW
ACS Chem Biol; 2013 Aug; 8(8):1737-46. PubMed ID: 23672401
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria.
Rajaputra P; Nkepang G; Watley R; You Y
Bioorg Med Chem; 2013 Jan; 21(2):379-87. PubMed ID: 23245573
[TBL] [Abstract][Full Text] [Related]
39. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo.
Jang B; Park JY; Tung CH; Kim IH; Choi Y
ACS Nano; 2011 Feb; 5(2):1086-94. PubMed ID: 21244012
[TBL] [Abstract][Full Text] [Related]
40. Enhanced two-photon singlet oxygen generation by photosensitizer-doped conjugated polymer nanoparticles.
Shen X; He F; Wu J; Xu GQ; Yao SQ; Xu QH
Langmuir; 2011 Mar; 27(5):1739-44. PubMed ID: 21247190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
